Below are the first 10 and last 10 pages of uncorrected machine-read text (when available) of this chapter, followed by the top 30 algorithmically extracted key phrases from the chapter as a whole.
Intended to provide our own search engines and external engines with highly rich, chapter-representative searchable text on the opening pages of each chapter. Because it is UNCORRECTED material, please consider the following text as a useful but insufficient proxy for the authoritative book pages.
Do not use for reproduction, copying, pasting, or reading; exclusively for search engines.
OCR for page 168
Distribution and Administration of Potassium Iodide in the Event of a Nuclear Incident REFERENCES Adams, W. H., Heotis, P. M., Scott, W. A. Medical Status of Marshallese Accidentally Exposed to 1954 BRAVO Fallout Radiation. January 1985-December 1987. Upton, NY: Brookhaven National Laboratory. BNL-52192. 1987. AAP (American Academy of Pediatrics). Radiation Disasters and Children. Policy Statement. Organizational Principles to Guide and Define the Child Health Care System and/or Improve the Health of Children. Committee on Environmental Health. Pediatrics, June 2003. APWU (American Postal Workers Union). Potassium Iodide: Informational Sheet. APWU, Safety and Health, Industrial Relations. 2002. Astbury, J., Horsley S., Gent, N. Evaluation of a Scheme for the Pre-Distribution of Stable Iodine (Potassium Iodate) the Civilian Population Residing Within the Immediate Countermeasures Zone of a Nuclear Submarine Construction Facility. J Public Health Med 21: 412-414. 1999. Baverstock, K., Egloff, B., Pinchera, A., Williams, D. Thyroid Cancer after Chernobyl. Nature 359: 21-22. 1992. Blum, M., Eisenbud, M. Reduction of Thyroid Irradiation from 131I by Potassium Iodide. JAMA 200:1036-40. 1967.
OCR for page 169
Distribution and Administration of Potassium Iodide in the Event of a Nuclear Incident BMU: Basic Recommendations for Emergency Preparedness in Areas Surrounding Nuclear Facilities. German Ministry for the Environment, Nature Preservation and Nuclear Safety, Bonn. 1999. Braverman, L. E., Ingbar, S. H. Changes in Thyroidal Function during Adaptation to Large Doses of Iodide. J Clin Invest 42:1216-1231. 1963. Cardis, E., Amoros, E., Kesminiene, A., Malakhova, I. V., Poliakov, S. M., Piliptsevitch, N. N., Demidchik, E. P., Astakhova, L. N., Ivanov, V. K., Konogorov, A. P., Parshkov, E.P., Tsyb, A. F. Observed and Predicted Thyroid Cancer Incidence Following the Chernobyl Accident. Evidence for factors influencing susceptibility to radiation induced thyroid cancer. In: Radiation and Cancer. Thomas, G., Karaoglou, A., Williams, E. D., Eds. World Scientific Publishing, pp. 395-405. 1999. Cate, S., Ruttenber, A. J., Conklin, A. W. Feasibility of an Epidemiologic Study of the Thyroid Neoplasia in Persons Exposed to Radionuclides from the Hanford Nuclear Facility between 1994 and 1956. Health Physics 59: 169. 1990. Clemen, Robert T. Making Hard Decisions: An Introduction to Decision Analysis. Second edition, Duxbury Press: Pacific Grove, CA. pp. 547-550 on Swing Weights. 1996. Conference of Radiation Control Program Directors, Inc. (CRCPD). Resolution. May 6, 2002. Conklin, W. C. Memorandum from: W. Craig Conklin, Director Technological Services Division, Federal Emergency Management Agency. For: Regional Assistance Committee Chairs, Regions I-VII, IX, and X. Subject: Revision of “FEMA Guidance on the Use of Potassium Iodide by the General Public for Commercial Nuclear Power Plant Accidents.” 2002. Connecticut DPH (State of Connecticut Department of Public Health). Important Information on the Use of Potassium Iodide (KI) Tablets (available at the State of Connecticut Web site http://www.dph.state.ct.us/BCH/eeoh/ki/tablets.htm. 2003.
OCR for page 170
Distribution and Administration of Potassium Iodide in the Event of a Nuclear Incident Costa, A., Coltino, F., Ariano, M., Bacolla, A., Belleo, V., Chiecchio, A., Lorenzini, P. Comparison between Inhaled and Ingested Iodine Metabolism. The Journal of Nuclear Medicine and Allied Science, Vol. 26, No. 2, pp 89-96. 1982. Crick, M. S., Linsley, M. S. An Assessment of the Radiological Impact of the Windscale Fire. Int J Radiat Biol 46, 479-506. 1984. Crick, M. J., Linsley, G. S. An Assessment of the Radiological Impact of the Windscale Reactor Fire, October 1957. NRPB Report 135. HMSO London: National Radiation Protection Board. 1982. Dai, G., Levy, O., Carrasco, N. Cloning and Characterization of the Thyroid Iodide Transporter. Nature 379:458-460. 1996. DOT (Department of Transportation). Emergency Response Guidebook. Research and Special Programs Administration. 2000. Dubrova, Y. E., Grant, G., Chumak, A. A., Stezhka, V. A., Karakasian, A. N. Elevated Minisatellite Mutation Rate in the Post-Chernobyl Families from Ukraine. Am J Hum Genet 71: 801-809. 2002. Edwards, W. Multiattribute Utility Measurement: Evaluating Desegregation Plans in a Highly Political Context. In Perloff, R., ed., Evaluator Interventions: Pros and Cons. (pp. 13-54). Beverly Hills, CA: Sage Publications. 1979. Edwards, W. Reflections on and Criticism of a Highly Political Multiattribute Utility Analysis. In Cobb, L. and Thrall, R.M., eds., Mathematical Frontiers of Behavioral Policy Sciences (pp. 157-168). Boulder, CO: Westview Press. 1980. Eng, H. K., Cardona, G. R., Fang, S. L., Previti, M., Alex, S., Carrasco, N., Chin, W. W., Braverman, L. E.: Escape from the Acute Wolff-Chaikoff Effect is Associated with a Decrease in Thyroid Sodium/Iodide Symporter mRNA and Protein. Endocrinology 140:3404-3410. 1999. Engell, A., Lamm, S. H. Goitrogens in the Environment. In Diseases of the Thyroid. Ed. Lewis E. Braverman. pp 307-328. Humana Press, 2003.
OCR for page 171
Distribution and Administration of Potassium Iodide in the Event of a Nuclear Incident FEMA (Federal Emergency Management Agency). Federal Policy on Use of Potassium Iodide. Federal Register, 67(7):1355-1357. 2002. FEMA (Federal Emergency Management Agency). Guidance for Developing State, Tribal, and Local Radiological Emergency Response Planning and Preparedness for Transportation Accidents. Report No. FEMA-REP-5 Rev. 1. Federal Emergency Management Agency. 1992. FDA (Food and Drug Administration). Guidance for Federal Agencies and State and Local Governments: Potassium Iodide Shelf Life Extension. Draft Guidance. Rockville, MD: U.S. Department of Health and Human Services, Food and Drug Administration, Center for Food and Drug Evaluation Research. 2003a. FDA (Food and Drug Administration). Home Preparation Procedure for Emergency Administration of Potassium Iodide Tablets to Infants and Children Using 130 milligram (mg) Tablets. FDA Center for Drug Evaluation and Research, Washington DC, May 6. 2003b. FDA (Food and Drug Administration). Home Preparation Procedure for Emergency Administration of Potassium Iodide Tablets to Infants and Children Using 65 milligram (mg) Tablets. FDA Center for Drug Evaluation and Research, Washington DC, May 6. 2003c. FDA (Food and Drug Administration). Frequently Asked Questions on Potassium Iodide (KI). FDA Center for Drug Evaluation and Research, Washington DC, March 18. 2003d. FDA (Food and Drug Administration). Guidance for Industry. KI in Radiation Emergencies – Questions and Answers. Procedural, Revision 1. FDA Center for Drug Evaluation and Research, Washington DC, December. 2002. FDA (Food and Drug Administration). Guidance Potassium Iodide as a Thyroid Blocking Agent in Radiation Emergencies. Rockville, MD: U.S. Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research. 2001a.
OCR for page 172
Distribution and Administration of Potassium Iodide in the Event of a Nuclear Incident FDA (Food and Drug Administration). FDA Talk Paper. FDA’s Guidance on Protection of Children and Adults against Thyroid Cancer in Case of Nuclear Accident. FDA, Office of Public Affairs, Washington DC, December 10. 2001b. FDA (Food and Drug Administration). Accidental Radioactive Contamination of Human Food and Animal Feeds: Recommendations for State and Local Agencies. Rockville, MD: U.S. Department of Health and Human Services, Food and Drug Administration, Center for Devices and Radiological Health. 1998. FDA (Food and Drug Administration). Potassium Iodide as a Thyroid-Blocking Agent in a Radiation Emergency: Final Recommendations on Use. Federal Register 47:28158. 1982. FDA (Food and Drug Administration). Population Dose and Health Impact of the Accident at Three Mile Island Nuclear Station. HFX-1. Rockville, MD: Food and Drug Administration, Bureau of Radiological Health, May 10, 1979. FDA (Food and Drug Administration). Accidental Radioactive Contamination of Human and Animal Feeds and Potassium Iodide as a Thyroid-Blocking Agent in a Radiation Emergency. Washington, D.C.: U.S. Department of Health, Education, and Welfare (now U.S. Department of Heath and Human Services. Federal Register (43CFR58798). December 15. 1978. Fowinkle, E. W., Sell, S. H., Wolle, R. H. Predistribution of Potassium Iodide--the Tennessee Experience. Public Health Rep.98 (2):123-6. 1983. Gavrilin, Y. I., Khrouch, V. T., Shinkarev, S. M., Krysenko, N. A., Skryabin, A. M., Bouville, A., Anspaugh, L. R. Chernobyl Accident: Reconstruction of Thyroid Dose for Inhabitants of the Republic of Belarus. Health Physics, 76:105-119. 1999. Getaz, P. E., Shimaoka, K. Anaplastic Carcinoma of the Thyroid in a Population Irradiated for Hodgkin Disease, 1910-1960. J Surg Onc 12: 181-189. 1979.
OCR for page 173
Distribution and Administration of Potassium Iodide in the Event of a Nuclear Incident Gilbert, E. S., Tarone, R., Bouville, A., Ron, E. Thyroid Cancer Rates and 131I Doses from Nevada Atmospheric Nuclear Bomb Tests. J Natl Cancer Inst. 4; 90(21):1654-60. 1998. Goldsmith, J. R., Grossman, C. M., Morton, W. E., Nussbaum, R. H., Kordysh, E. A., Quastel, M. R., Sobel, R. B., Nussbaum, F. D. Juvenile Hypothyroidism Among Two Populations Exposed to Radioiodine. Environ Health Perspect Apr. 107(4):303-8. 1999. Hagstrom, R. M. History and procedures for use of potassium iodide (KI) as protective measures for the general public located around fixed nuclear facilities. Presentation to the NAS Committee to Assess the Distribution and Administration of Potassium Iodide in the Event of a Nuclear Incident. June 19, 2003. Hamilton, T. E., van Belle, G., LoGerfo, J. P. Thyroid Neoplasms in Marshall Islanders Exposed to Nuclear Fallout. Journal of the American Medical Association 258:629-636. 1987. Holm, L. E., Hall, P., Wiklund, K., Lundell, G., Berg, G., Bjelkengren, G., Cederquist, E., Ericsson, U. B., Hallquist, A., Larsson, L. G. Cancer Risk after Iodine-131 Therapy for Hyperthyroidism. J Nat Cancer Inst 83: 1072-1077. 1991. Hollowell, J. G., Staehling, N. M., Hannon, W. H., Flanders, D. W., Gunter, E. W., Maberly, G. F., Braverman, L. E., Pino, S., Miller, D. T., Garbe, P. L., DeLozier, D. M., and Jackson, R. J. Iodine Nutrition in the United States: Trends and Public Health Implications. Iodine Excretion Data from NHANES I and NHANES III (1971-1974 and 1988-1994). J. Clin. Endocrinol. Metab. 83:3401-3410. 1998. Hotspot 2.01 (Full 32 bit Windows 95/98/00/XP/NT Application). Lawrence Livermore National Laboratory, Nonproliferation/Arms Control/International Security, R Division and Hazards Control Department. November 7, 2002. IAEA (International Atomic Energy Agency). International Basic Safety Standards for Protection against Ionising Radiation and for the Safety of Radiation Sources. International Atomic Energy Agency, Vienna: IAEA Safety Series No. 115. 1996.
OCR for page 174
Distribution and Administration of Potassium Iodide in the Event of a Nuclear Incident IAEA (International Atomic Energy Agency). The International Chernobyl Project, 1990-91 Assessment of Radiological Consequences and Evaluation of Protective Measures Summary Brochure. Report by an International Advisory Committee, IAEA, Vienna. 1991. ICRP (International Commission on Radiological Protection). 1990 Recommendations of the International Commission on Radiological Protection. ICRP Publication 60, Annals of the ICRP 21(1-3). Elmsford, NY: Pergamon Press. 1991. ICRP (International Commission on Radiological Protection). Recommendations of the International Commission on Radiological Protection. ICRP Publication 26, Annals of the ICRP 1(3). Elmsford, NY: Pergamon Press. 1977. Kazakov, V. S., Demidchik, E. P., Astakhova, L. N. Thyroid Cancer after Chernobyl. Nature 359: 21. 1992. Keeney, R. Value-Focused Thinking: A Path to Creative Decisionmaking, Harvard University Press: Cambridge, Massachusetts. 1992. Keeney, R., Renn, O., von Winterfeldt, D. Structuring Germany’s Energy Objectives. Energy Policy, 15, pp. 352-362. 1987. Keeney, R., Raiffa, H. Decisions with multiple objectives: Preferences and Value Tradeoffs. Originally published by Wiley. Cambridge: Cambridge University Press. 1976. Keller, L. R., Kirkwood, C. W. The Founding of INFORMS: A Decision Analysis Perspective. Operations Research, 47(1), pp. 16-28. 1999. Kemeny, J. G., Babbitt, B., Haggetry, P. E., Lewis, C., Marks, P. A., Marrett, C. B., McBride, L., McPherson, H. C., Peterson, R. W., Pigford, T. H., Taylor, T. B., Trunk, A. D. Report of the President’s Commission on The Accident at Three Mile Island. Pergamon Press, Inc., New York, ISBN-0-08-025946-4. 1979. Kodaira, M., Satoh, C., Hiyama, K., Toyama, K. Lack of Effects of Atomic Bomb Radiation on Genetic Instability of Tandem-Repetitive Elements in Human Germ Cells. Am J Hum Genet. 57(6):1263-6. 1995.
OCR for page 175
Distribution and Administration of Potassium Iodide in the Event of a Nuclear Incident Langer, S., Russell, M. L., Akers, D. W. Fission Product Release Pathways in Three Mile Island Unit 2. Nucl Technol 87: 196-204. 1989. Lee, W., Chiacchierini, R. P., Shleien, B., Telles, N. C. Thyroid Tumors Following 131I or Localized X Irradiation to the Thyroid and Pituitary Glands in Rats. Radiat Res. 92:307-19. 1982. Le Guen, B., Hémidy, P. Y., Garcier, Y. French Approach for the Distribution of Iodine Tablets in the Vicinity of Nuclear Power Plants. Health Phys 83: 293-300. 2002. Leissa, B. FDA guidance on KI use, dosing for special populations, and shelf life extension. Presentation by the FDA Lead Medical Officer to the Committee to Assess Distribution and Administration of Potassium Iodide in the Event of a Nuclear Incident. FDA Division of Counter-Terrorism. Presented at the National Academies Building, Washington DC, May 29. 2003. Likhtarev, I. A., Gulko, G. M., Kairo, I. A., Los, I. P., Henrichs, K., Paretzke, H. G. Thyroid Doses Resulting from the Ukraine Chernobyl Accident-part I: Dose Estimates for the Population of Kiev. Health Physics 66:137-146. 1994. Likhtarev, I. A., Shandala, N. K., Gulko, G. M., Kairo, I. A., Chepurny, N. I. Ukrainian Thyroid Doses after the Chernobyl Accident. Health Physics 64:594-599. 1993. Little, J. B., Nagasawa, H., Pfenning, T., Vetrovs, H. Radiation-Induced Genomic Instability: Delayed Mutagenic and Cytogenetic Effects of X rays and Alpha Particles. Radiat Res. 148(4):299-307. 1997. Lorimore, S. A., Wright, E. G. Radiation Induced Genomic Instability and Bystander Effects: Related Inflammatory-Type Responses to Radiation Induced Stress and Injury? A review. Int J Radiat Biol. 79: 15-25. 2003. Lund, E., Galanti, M.R. Incidence of Thyroid Cancer in Scandinavia Following Fallout from Atomic Bomb Testing. Cancer Causes Control 10: 181-187. 1999.
OCR for page 176
Distribution and Administration of Potassium Iodide in the Event of a Nuclear Incident LCNE (Lunder Committee for Nuclear Energy). Basic Recommendations for Emergency Preparedness in Areas Surrounding Nuclear Facilities. Germany. 1999. NCI (National Cancer Institute). Estimated Exposure and Thyroid Doses Received by the American People from Iodine-131 in Fallout Following Nevada Atmospheric Nuclear Bomb Tests. A report from the National Cancer Institute. Rockville, MD: U.S. Department of Health and Human Services. 1997. NCRP (National Council on Radiation Protection and Measurements). Management of Terrorist events Involving Radioactive Material. NCRP Report No. 138. Bethesda, MD: National Council on Radiation Protection and Measurements. 2001. NRC (National Research Council). Exposure of the American People to Iodine-131 from Nevada Nuclear Bomb Tests. Review of the National Cancer Institute Report and Public Health Implications. Washington DC: National Academy Press. 1999. NRC (National Research Council). Improving Risk Communication, Committee on Risk Perception and Communication. Washington, DC: National Academy Press. 1989. Nauman, J., Wolff, J. Iodide Prophylaxis in Poland after the Chernobyl Reactor Accident: Benefits and Risks. AJM 94: 524-532. 1993. Nuclear information bulletin. Middletown, PA: General Public Utilities. June 1990. NEA/OECD (Nuclear Energy Agency/Organization for Economic Co-operation and Development). Short-Term Countermeasures in Case of a Nuclear or Radiological Emergency. OECD Publications, 75775. Paris, CD 16. 2003. Pisarev M. A., Gartner R. Autoregulatory Actions of Iodine. In The Thyroid: A Fundamental and Clinical Text. Eighth Edition, L. E. Braverman and R. D. Utiger, Eds. pp 85-90. 2000. Pietrzak-Flis, Z., Krajewski, P., Radwin, I., Muramatsu, Y. Retrospective Evaluation of 131I Deposition Density and Thyroid Dose in Poland after the Chernobyl Accident. Health Physics 84: 698-708. 2003.
OCR for page 177
Distribution and Administration of Potassium Iodide in the Event of a Nuclear Incident Ramsdell, J. V. Jr., Simonen, C. A., Burk, K. W., Stage, S. A. Atmospheric Dispersion and Deposition of 131I Released from the Hanford Site. Health Phys Oct 71(4):568-77. 1996. Ramsden, D., Passant, F. H., Peabody, C. O., Speight, R. G. Radioiodine Uptakes in the Thyroid Studies of the Blocking and Subsequent Recovery of the Gland Following the Administration of Stable Iodine. Health Physics 13:633-46. 1967. Reid, D. Testimony before the Committee to Assess the Distribution and Administration of Potassium Iodide in the Event of a Nuclear Incident. July 25. 2003. Robkin, M. Experimental Release of I-131: The Green Run. Health Physics 62: 487-495. 1992. Rogers, D. L. Practical Experience with KI Distribution. The Maryland Experience. Presentation to the American Thyroid Association Symposium, February 28, 2003. Ron, E., Lubin, J. H., Shore, R. E., Mabuchi, K., Modan, B., Pottern, L.M., Schneider, A. B., Tucker, M. A., Boice, J. D. Jr.. Thyroid Cancer after Exposure to External Radiation, a Pooled Analysis of 7 Studies. Radiation Research 141: 259-277. 1995. Roti, E., Colzani, R., Braverman, L. E. Adverse Effects of Iodine on the Thyroid. The Endocrinologist 7:245-254. 1997. Sankaranarayanan, K. Nature of Spontaneous Radiation Induced Mutations in Mammalian in Vitro Systems and Mechanisms of Induction of Mutations by Radiation. Mutation Research 258, 75-97. 1991. Scranton WW II. Report of the Governor’s Commission on Three Mile Island. Commonwealth of Pennsylvania. February 26, 1980. Sharon, M. J. Potassium Iodide Distribution in Maryland. Planning and Policy Issues. Presentation to the American Thyroid Association Symposium, February 28, 2003. Shore, R. E., Hildreth, N., Dvoretsky, P., Pasternack, B., Andressa, E. Benign Thyroid Adenomas Among Persons X Irradiated in Infancy for Enlarged Thymus Glands. Radiation Research 134: 217-223. 1993.
OCR for page 178
Distribution and Administration of Potassium Iodide in the Event of a Nuclear Incident Sternthal, E., Lipworth, L., Stanley, B., Abreau, C., Fang, S., and Braverman, L. E. Suppression of Thyroid Radioiodine Uptake by Various Doses of Stable Iodide. New Engl. J. Med. 303:1083-088. 1980. SSK (Die Strahlenschutzkommission, German Radiological Protection Commission). Implementation of Iodine Blockade in a Nuclear Emergency. German Radiological Protection Commission, Bonn. 1997. Takahashi, T., Trott, K. R., Fujimori, K., Nakashima, N. Ohtomo, H., Schoemaker, M. J., Simon, S. L. Thyroid Disease in the Marshall Islands. Findings from 10 years of Study. Marshall Islands Nationwide Thyroid Disease Study. Tohoku University Press, Sendai. 2001. Talbott, E. O., Youk, A. O., McHugh, K. P., Shire, J. D., Zhang, A., Murphy, B. P., Engberg, R. A. Mortality among the Residents of the Three Mile Island Accident Area: 1979-1992. Environ Health Perspect 108:545-552. 2000. The Medical Letter. Potassium iodide for thyroid protection in a nuclear accident or attack. The Medical Letter on Drugs and Pharmaceuticals. Volume 44, November 11. 2002. Thompson, D. E., Mabuchi, K., Ron, E., Soda, M., Tokunaga, M., Ochikubo, S., Sugimoto, S., Ikeda, T., Terasaki, M., Izumi, S., Preston, D. L. Cancer Incidence in Atomic Bomb Survivors. Part II: Solid Tumors, 1958-1987. Radiation Research 137: S17-S67. 1994. UNSCEAR (United Nations Scientific Committee on the Effects of Atomic Radiation). Exposures and Effects of the Chernobyl Accident. Annex J In Sources and Effects of Ionizing Radiation. Volume II: EFFECTS. United Nations, New York and Geneva. 2000. USEPA (US Environmental Protection Agency). Manual of Protective Action Guides and Protective Actions for Nuclear Incidents. Report No. EPA 400-R-92-001. Washington, D.C.: US. Environmental Protection Agency. 1992. USNRC (US Nuclear Regulatory Commission). Assessment of the Use of Potassium Iodide (KI) as a Supplemental Public
OCR for page 179
Distribution and Administration of Potassium Iodide in the Event of a Nuclear Incident Protective Action during Severe Reactor Accidents. Draft NUREG-1633. November 26, 2002. USNRC (US Nuclear Regulatory Commission). Source Term Estimation during Incident Response to Severe Nuclear Power Plant Accidents. Washington, DC: US Nuclear Regulatory Commission, Division of Operational Assessment. NUREG-1228. October 1988. USNRC (US Nuclear Regulatory Commission). Report on the Accident at the Chernobyl Nuclear Power Station. NUREG-1250. January 1987. USNRC (US Nuclear Regulatory Commission). Criteria for Preparation and Evaluation of Radiological Emergency Response Plans and Preparedness in Support of Nuclear Power Plants. Report No. NUREG-0654 Rev.1/FEMA-REP-1 Rev.1. US Nuclear Regulatory Commission and Federal Emergency Management Agency. 1980. USNRC (US Nuclear Regulatory Commission). Investigation into the March 28, 1979 Three Mile Island Accident by Office of Inspection and Enforcement. Investigation Report No. 50-320/79-10. NUREG-0600. Washington, D.C.: Office of Inspection and Enforcement US Nuclear Regulatory Commission. 1979. USNRC (US Nuclear Regulatory Commission). Reactor Safety Study: An Assessment of the Accident Risks in US Commercial Nuclear Power Plants. WASH-1400 (NUREG-75/014), Washington, DC. October 1975. USPS (US Postal Service) Proactive on Public Safety. USPS Department of Public Affairs and Communication. USPS News Today, December 4. 2002a. USPS (US Postal Service) Postal Service Statement on Employees and Potassium Iodide. December 3. 2002b. Vargo, G. J., Bar'yakhtar, V., Kholosha, V., Kukhar', V., Los', I., Poyarkov, V., Shestopalov, V. The Chornobyl Accident: A Comprehensive Risk Assessment. Battelle Press: Columbus, OH. 2000.
OCR for page 180
Distribution and Administration of Potassium Iodide in the Event of a Nuclear Incident von Winterfeldt, D., Edwards, W. Decision Analysis and Behavioral Research. Cambridge University Press: Cambridge, UK, swing weights, pp. 274-5, 286-7. 1986. Weidner, W. A., Miller, K. L., Rohrer, G. V., Latshaw, R. F. The Impact of a Nuclear Crisis on a Radiology Department. Radiology 135, Number 3, 717-723. 1980. Williams, E. D. Cancer after Nuclear Fallout: Lessons from the Chernobyl Accident. Nature Reviews Cancer 2: 543-549. 2002. Williams, E. D. Biological Mechanisms Underlying Radiation Induction of Thyroid Carcinoma. In Radiation and Thyroid Cancer, Thomas G, Karaoglou A and Williams ED (eds). World Scientific, Singapore. 1999. Williams, E. D. One Decade after Chernobyl. Summing up the Consequences of the Accident. Proceedings of an International Conference, Vienna. 1996. Winn, M. I., Keller, L. R. Harnessing Complexity, Idiosyncrasy and Time: A Modeling Methodology for Corporate Multi-Stakeholder Decisions. In Wood, D.J. and Windsor, D. (Eds.), International Association for Business and Society 1999 Proceedings of Tenth Annual conference held in Paris, France, June 1999, 482-487. 1999. Winn, M. I., Keller, L. R. A Modeling Methodology for Multi-Objective Multi-Stakeholder Decisions: Implications for Research. Journal of Management Inquiry, 10, pp. 166-181. 2001. Wolff, J., Chaikoff, I. L., Goldberg, R. C., Meier, J. R. The temporary nature of the inhibitory action of excess iodide on organic iodine synthesis in the normal thyroid. Endocrinology. 45:504-513. 1949. Wolff, J., Chaikoff, I. L., Rosenfeld, S. Inhibiting effect of inorganic iodide on the formation in vitro of thyroxine and diiodotyrosine by surviving thyroid tissue. J Biol Chem. 154:381-387. 1944. WHO (World Health Organization). Guidelines for Iodine Prophylaxis Following Nuclear Accidents, Report No.
OCR for page 181
Distribution and Administration of Potassium Iodide in the Event of a Nuclear Incident WHO/SDE/PHE99.6, Update 1999, World Health Organization, Geneva. 1999. WHO (World Health Organization). Guidelines for Iodine Prophylaxis following Nuclear Accidents. World Health Organization, Geneva. 1989. Yamashita, S., Shibata, Y., Hoshi, M., Fujimura, K. Chernobyl: Message for the 21st Century. Sasakawa Medical Cooperation Symposium 2001 Moscow. Elsevier Amsterdam. 2002. Zanzonico, P. B., Becker, D. V. Effects of Time of Administration and Dietary Iodine Levels on Potassium Iodine (KI) Blockade of Thyroid Irradiation by 131I from Radioactive Fallout. Health Physics 78:660-667. 2000.
OCR for page 182
Distribution and Administration of Potassium Iodide in the Event of a Nuclear Incident This page intentionally left blank.
Representative terms from entire chapter: